Nivolumab for Relapsed/Refractory Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure – Polish Lymphoma Research Group Real-Life Experience
Acta Haematologica Polonica - Poland
doi 10.2478/ahp-2018-0026
Full Text
Open PDFAbstract
Available in full text
Date
December 31, 2018
Authors
Publisher
Walter de Gruyter GmbH